Sheep And Goat Pox Vaccines Global Market Report 2025

Description

Sheep and goat pox vaccines are specifically developed to prevent diseases caused by viruses belonging to the Capripoxvirus genus, which include sheep pox and goat pox. These vaccines play a critical role in preventing and managing outbreaks among sheep and goat populations, as both diseases can lead to significant economic losses due to high mortality rates and reduced productivity. They function by stimulating the immune system to generate antibodies against the viruses, thereby providing protection from infection.

The primary types of sheep and goat pox vaccines include live attenuated vaccines, inactivated vaccines, and others. Live attenuated vaccines use weakened forms of the virus to stimulate the immune system without causing severe illness. They are particularly effective for diseases such as sheep and goat pox where a robust immune response is necessary for effective protection. These vaccines are administered via various routes such as injectable and intranasal applications for sheep and goats.

The sheep and goat pox vaccines research report is one of a series of new reports from The Business Research Company that provides sheep and goat pox vaccines market statistics, including the sheep and goat pox vaccines industry's global market size, regional shares, competitors with a sheep and goat pox vaccines market share, detailed sheep and goat pox vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the sheep and goat pox vaccines industry. This sheep and goat pox vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sheep and goat pox vaccines market size has grown steadily in recent years. It will grow from $57.79 billion in 2024 to $60.58 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to increased outbreaks of sheep and goat pox, government vaccination programs, advancements in veterinary medicine, high mortality rates in livestock, increased awareness among farmers, economic losses due to disease, trade restrictions on affected areas, improved diagnostic techniques, the historical prevalence of the disease, and collaboration between veterinary institutions.

The sheep and goat pox vaccines market size is expected to see steady growth in the next few years. It will grow to $72.47 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to the growing demand for livestock products, expanding livestock farming, government subsidies for vaccines, rising investment in veterinary research, technological advancements in vaccine production, increasing awareness of animal health, international trade agreements, climate change impacting disease patterns, the emergence of new vaccine technologies, economic growth in developing regions. Major trends in the forecast period include the development of multivalent vaccines, increasing use of recombinant vaccines, growing focus on vaccine safety, rise in public-private partnerships, expansion of veterinary vaccine market, digital tracking of vaccination programs, increased funding for animal health research, regional disease eradication initiatives, growing adoption of sustainable farming practices, enhanced regulatory frameworks for vaccines.

The increasing demand for livestock products is poised to drive growth in the market for sheep and goat pox vaccines. Livestock products encompass various goods derived from domesticated animals raised in agricultural settings. This rising demand stems from factors such as income and population growth, urbanization, health considerations, evolving consumer preferences, globalization, trade, and economic development. Sheep and goat pox vaccines play a crucial role in protecting livestock products by preventing disease outbreaks and ensuring the health and productivity of sheep and goat populations. For example, in February 2024, the Department for Environment, Food, and Rural Affairs noted an increase in red meat production, particularly mutton and lamb, with the largest rise recorded at 2.9%. Additionally, total domestic fish production in 2022 slightly exceeded 4,182 million metric tons, up from 4,178 million metric tons in 2020. Hence, the growing demand for livestock products is expected to drive expansion in the sheep and goat pox vaccines market.

Major companies in the sheep and goat pox vaccine market are concentrating on the development of innovative products, such as live attenuated vaccines, to improve immune responses while minimizing side effects. Live attenuated vaccines contain live viruses or bacteria that have been weakened in the laboratory to prevent them from causing disease in healthy individuals. These vaccines stimulate a strong immune response by simulating a natural infection without causing illness. For example, in August 2022, the Indian Council of Agricultural Research, based in India, developed Lumpi-ProVacInd to fight Lumpy Skin Disease (LSD) in cattle. This vaccine is intended for preventive immunization, providing immunity for at least one year with a single dose that contains 103.5 TCID50 of the attenuated LSD virus. It is safe for animals, induces a strong immune response, and must be stored at 4°C, requiring careful handling during transportation and use.

In September 2022, Hester Biosciences Limited, an India-based animal healthcare company, acquired the manufacturing technology for the Goat Pox vaccine (Uttarkashi Strain) from the Indian Veterinary Research Institute (IVRI) for an undisclosed sum. This acquisition enables Hester to supply the goat pox vaccine through state government tenders for cattle immunization against lumpy skin disease in various states. The Indian Veterinary Research Institute, a prominent institution for livestock research and development in India, facilitated this technology transfer.

Major companies operating in the sheep and goat pox vaccines market are Indian Immunologicals Ltd., Kemin Industries, Bimeda Biologicals, Hester Biosciences Limited, Dollvet, MSD Animal Health, MCI Sante Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer's Pharma Private Limited, Institute of Veterinary Biological Products

North America was the largest region in the sheep and goat pox vaccines market in 2024. The regions covered in the sheep and goat pox vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sheep and goat pox vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sheep and goat pox vaccines market consists of sales of recombinant vaccines and subunit vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sheep And Goat Pox Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sheep and goat pox vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sheep and goat pox vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sheep and goat pox vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Live Attenuated Vaccines; Inactivated Vaccines; Other Types
2) By Route Of Administration: Injectable; Intranasal
3) By Application: Sheep; Goat
Subsegments:
1) By Live Attenuated Vaccines: Monovalent Live Attenuated Vaccines; Multivalent Live Attenuated Vaccines
2) By Inactivated Vaccines: Adjuvanted Inactivated Vaccines; Non-Adjuvanted Inactivated Vaccines
3) By Other Types: Recombinant Vaccines; DNA-Based Vaccines
Companies Mentioned: Indian Immunologicals Ltd.; Kemin Industries; Bimeda Biologicals; Hester Biosciences Limited; Dollvet
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31208

1. Executive Summary

2. Sheep And Goat Pox Vaccines Market Characteristics

3. Sheep And Goat Pox Vaccines Market Trends And Strategies

4. Sheep And Goat Pox Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Sheep And Goat Pox Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Sheep And Goat Pox Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Sheep And Goat Pox Vaccines Market Growth Rate Analysis
5.4. Global Sheep And Goat Pox Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Sheep And Goat Pox Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Sheep And Goat Pox Vaccines Total Addressable Market (TAM)

6. Sheep And Goat Pox Vaccines Market Segmentation

6.1. Global Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Vaccines
Inactivated Vaccines
Other Types
6.2. Global Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable
Intranasal
6.3. Global Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sheep
Goat
6.4. Global Sheep And Goat Pox Vaccines Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monovalent Live Attenuated Vaccines
Multivalent Live Attenuated Vaccines
6.5. Global Sheep And Goat Pox Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adjuvanted Inactivated Vaccines
Non-Adjuvanted Inactivated Vaccines
6.6. Global Sheep And Goat Pox Vaccines Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Vaccines
DNA-Based Vaccines

7. Sheep And Goat Pox Vaccines Market Regional And Country Analysis

7.1. Global Sheep And Goat Pox Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Sheep And Goat Pox Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sheep And Goat Pox Vaccines Market

8.1. Asia-Pacific Sheep And Goat Pox Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sheep And Goat Pox Vaccines Market

9.1. China Sheep And Goat Pox Vaccines Market Overview
9.2. China Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sheep And Goat Pox Vaccines Market

10.1. India Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sheep And Goat Pox Vaccines Market

11.1. Japan Sheep And Goat Pox Vaccines Market Overview
11.2. Japan Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sheep And Goat Pox Vaccines Market

12.1. Australia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sheep And Goat Pox Vaccines Market

13.1. Indonesia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sheep And Goat Pox Vaccines Market

14.1. South Korea Sheep And Goat Pox Vaccines Market Overview
14.2. South Korea Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sheep And Goat Pox Vaccines Market

15.1. Western Europe Sheep And Goat Pox Vaccines Market Overview
15.2. Western Europe Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sheep And Goat Pox Vaccines Market

16.1. UK Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sheep And Goat Pox Vaccines Market

17.1. Germany Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sheep And Goat Pox Vaccines Market

18.1. France Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sheep And Goat Pox Vaccines Market

19.1. Italy Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sheep And Goat Pox Vaccines Market

20.1. Spain Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sheep And Goat Pox Vaccines Market

21.1. Eastern Europe Sheep And Goat Pox Vaccines Market Overview
21.2. Eastern Europe Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sheep And Goat Pox Vaccines Market

22.1. Russia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sheep And Goat Pox Vaccines Market

23.1. North America Sheep And Goat Pox Vaccines Market Overview
23.2. North America Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sheep And Goat Pox Vaccines Market

24.1. USA Sheep And Goat Pox Vaccines Market Overview
24.2. USA Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sheep And Goat Pox Vaccines Market

25.1. Canada Sheep And Goat Pox Vaccines Market Overview
25.2. Canada Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sheep And Goat Pox Vaccines Market

26.1. South America Sheep And Goat Pox Vaccines Market Overview
26.2. South America Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sheep And Goat Pox Vaccines Market

27.1. Brazil Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sheep And Goat Pox Vaccines Market

28.1. Middle East Sheep And Goat Pox Vaccines Market Overview
28.2. Middle East Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sheep And Goat Pox Vaccines Market

29.1. Africa Sheep And Goat Pox Vaccines Market Overview
29.2. Africa Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sheep And Goat Pox Vaccines Market Competitive Landscape And Company Profiles

30.1. Sheep And Goat Pox Vaccines Market Competitive Landscape
30.2. Sheep And Goat Pox Vaccines Market Company Profiles
- 30.2.1. Indian Immunologicals Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Kemin Industries Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bimeda Biologicals Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Hester Biosciences Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Dollvet Overview, Products and Services, Strategy and Financial Analysis

31. Sheep And Goat Pox Vaccines Market Other Major And Innovative Companies

31.1. MSD Animal Health
31.2. MCI Sante Animale
31.3. Creative Biolabs
31.4. Biovex Inc.
31.5. Advacare Pharma
31.6. Brilliant Bio Pharma Private Limited
31.7. Intervac (PVT) Ltd.
31.8. Agrinnovate India Limited
31.9. Bio-Med Pvt Limited
31.10. JOVAC
31.11. Vetal Animal Health Products
31.12. Kenya Veterinary Vaccines Production Institute
31.13. Vedall Pharma Private Limited
31.14. Farmer's Pharma Private Limited
31.15. Institute of Veterinary Biological Products

32. Global Sheep And Goat Pox Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sheep And Goat Pox Vaccines Market

34. Recent Developments In The Sheep And Goat Pox Vaccines Market

35. Sheep And Goat Pox Vaccines Market High Potential Countries, Segments and Strategies

35.1 Sheep And Goat Pox Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Sheep And Goat Pox Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Sheep And Goat Pox Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer